ascendis pharma glp-1 Novo Nordisk signs deal for monthly agonist Novo puts $285m into monthly
Description
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Welcome to TODAY'S AJENDA!
GLP-1 drops Oral Drops GLP-1 Drops are a prescription medication used to support blood sugar control in adults with type 2 diabetes
Additional medications such as sulfonylureas, dipeptidyl-peptidase-4 inhibitors, thiazolidinediones, and glucagon-like peptide-1 receptor agonists should be added as needed in a patient-centered fashion
Understanding the timeline and effects of temporary treatment helps you make informed decisions about your weight loss journey
Covering GLP-1s through a group health plan ties cost directly to utilization, and GLP-1 utilization isn't slowing down
